Immunotech Laboratories Inc (IMMB)

[NanoEE]

CSO Harry Zhabilov stated, "As the Company progresses in its efforts to commercialize all the current and yet to be discovered opportunities of its patented treatments, the addition of IMBL and the benefits of obtaining an EMA permit has opened up new and exciting avenues for growth of our Company and the associated potential increase in value to its shareholders."

Sounds familiar?!?!

It was the same spiel he gave when the Merger between Bioclonetics and Enzolytics happened.

https://finance.yahoo.com/news/enzolytics-finalizes-documentation-international-medical-130000414.html

I will have to dig around, but to get European approval doesn't require a European business.

[Dodgeball]

Certainly looks like $IMMB owns the IP. Lots of references to plans and agreements in $ENZC filings, but never an entry that says they were completed. Same on the stock swap, which would have left $IMMB owning a substantial portion of $ENZC.

[NanoEE]

ITSI merger

https://yahoo.brand.edgar-online.com/DisplayFilingInfo.aspx?Type=HTML&text=%26lt%3bNEAR%2f4%26gt%3b(%22JOSEPH+L.%22,%22PITTERA%22)&FilingID=6478228&ppu=/PeopleFilingResults.aspx?PersonID=2977324&PersonName=JOSEPH%20L.%20PITTERA

Viral to IMMB

https://fintel.io/doc/sec-immb-8k-immunotech-laboratories-2012-june-13-18589

[NanoEE]

https://www.sec.gov/Archives/edgar/data/1137117/000101738611000003/immb_2009dec31-10k.htm

Just adding to the board, info for later.

[NanoEE]

All talk and no action.

Did Harry promise Dimitri(?) and not fulfill the end agreements.

This is where Dimitri is holding on to this licensing agreement for the ImmunH(ITV1).

And by the filling “exclusive rights” is what I recall.

This is the bad blood between the two then?!?!

I have a sneaky suspicion Harry is too immature to be patient in his medical developments. He is trying to make a quick buck fast and he is breaking a lot of bonds in his venture.

[Dodgeball]

That's a good point. The inference then being that $IMMB owns all the IP rights and 49% interest in Immunotech BG. However, $ENZC filings seem to indicate the opposite, but the merely mention the intention to make the swaps, not that they ever happened. And as you point out, there was never a SEC filing on the share distribution or redistribution. This suggests that $IMMB owns quite a bit, and there appears to be a desire to keep that quiet.

[NanoEE]

I read through that too fast.

I am gathering that there has been nothing done about this, since I have never seen an SEC filing on the share distribution or re-distribution.

[NanoEE]

That is a very good find. Does ITV1 change to another compound name?!?!

[Dodgeball]

This sheds some light on who owns whats, provided the deal came to fruition.

From the EPCO/$ENZC September 30,2017 Quarterly...

On March 9, 2017, theCompany entered into an agreement with the shareholders of Immunotech Laboratories, Inc. (Immunotech) to acquire all of the outstanding shares, both preferred and common stock. The 60,000,000 million Immunotech Series A preferred shares are being exchanged one for one for the Newly Created ECPO Preferred Series A with the exact same voting preference as the Immunotech Series A preferred. Immunotech’s 200 Million outstanding Series B Preferred are being exchanged two for one but do have a voting preferenceand shall be exchanged for 100 Million Series B Preferred shares of ECPO with the exact same voting preferences as the Immunotech Series B Preferred. The Company will issue 291,578,947series B preferred in exchange of 574,964,967 of common stock of Immunotech. This transaction is still in process. Currently the Company has acquired voting control and majority ownership of Immunotech Laboratories, Inc. At the effective time of the Acquisition, all options to acquire common stock of Immunotech issued and outstanding, whether vested or unvested, shall automatically be converted into and become options to purchase shares of Common Stock. Upon conversion of the Newly Created ECPO series B the shareholders of IMMB participating in the Share Exchange Agreement will own 80% of the issued and outstanding of ECPO. No common stock of ECPO will be issued until the Newly Created Preferred Series B is Converted.

September 30,2017 Quarterly

[Dodgeball]

Yes. Lots of friction between Dimitar and Harry. One important point though is that the IP and other assets of $IMMB belong to the $IMMB shareholders. They are not the property of Harry or Dimitar or any individual.

[Dodgeball]

Interesting that the sub-page is still up, but the home page is blocked. More interesting that the $IMMB page actually links to the $ENZC website. They are still very entangled, and there is an unanswered question of who may be the subsidiary of whom.

Meanwhile, someone just shot a $0.02 spitball at $IMMB after earlier sub penny spitballs. Going to have to do A LOT better than that if you want my $IMMB shares.

[NanoEE]

Sounds like a fight between them all.

https://www.facebook.com/Immunotech-Laboratories-BG-102701388364128/?hc_ref=ARRJKBYQfWQlcdquQshnKyPGvAL3yMPl8R99nCC9U1VVX11QdzCIBL27BeMSrRcELXw&fref=nf&__tn__=kC-R

Where is what?

When to sell the pump and dumps.

[Dodgeball]

It's hard to say the termination ever occurred, thus hard to say IMMB doesn't still hold the IP. I saw the shenanigans on the ENZC board. This appears to be a touchy topic with some folks. Meanwhile, somebody puts in some ridiculous sub penny nuisance trades, maybe to try to scare IMMB long shareholders.

[NanoEE]

http://immunotechlab.com/sec-filings/

Wow, you read this and they rebuttal a lot of speculations out there.

And this is the SEC section?!?!

I may need clarity on these claims, from what I am reading Harry can’t terminate the terms with IMMB.

[NanoEE]

There is a form filed from Harry or Enzolytics Inc. to IMMB for termination of the license agreement between The Zhabilov Trust and IMMB. But as it stands the terms of the termination have not been SEC stamped.

I walked into the ENZC board on a mission to bust all the details I could between The Zhabilov Trust, IMMB, ENZC and BSSP. A lot of those people probably have me on ignore, lol, I was rash and I had a mission to clear the air.

I got a lot of push back, but those were people that did not have enough information or knowledge on the subject at whole. And for those that started providing SEC documents and information on documents filed started proving fruitful. I wish God Father(on the ENZC board) would have not deleted our conversations. But for whatever reason that poster deleted some good information. Either they didn’t want details out on the ENZC board or they didn’t want the facts out there. Sure you can argue that information can be sought on the internet, but why delete it?

Funny thing about BSSP, nobody came back with a rebuttal or facts, that one lies in limbo with me as well. I guess I could walk into the BSSP board with the same direction

[Dodgeball]

Two very small trades today: one for 5000 @ $0.02 and a second for 200 shares @ $0.0194 - that's a $3.88 trade, which is less than the commission. Somebody is playing games to find a price.

[Dodgeball]

$IMMB is not currently suspended. It trades on the Expert Market, so there is no publicly quoted Bid/Ask. Volume is low, and prices have been ranging from $0.01 to $0.04, making it difficult to determine a market value.

Harry needs to get the filings up to date. As of the last Annual Report filed, the company had $10,000,000 in intangible assets, 49% ownership in ImmunoTech BG. In the interim, they may have acquired shares in $ENZC. And IF any assets were transferred to $ENCZ we need to know what was paid for them. Otherwise they still belong to the $IMMB shareholders.

[NanoEE]

I apologize, I wrongly interpreted your question.

And I would say no to that question.

You don’t just get into Texas A&M, there has to be reason.

You would hate to be pulled up on the carpet for your claims in a facility that the government likes to work out of.

But thank you for that link to the deeper details of Harry and the origins.

Makes me really wonder who Harry is?!?!

With that I am pulling myself as a moderator and viewing both penny stocks as it is a penny stock.

Thanks again.

Stay thirsty my friend

[HESG]

pennies from heaven

[samsamsamiam]

The SEC can only suspend a stock for 10 days.
That’s what happened.


The problem is if ENZC is doing the same thing this stock was suspended for?




See also:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162381684

[NanoEE]

With in your link are you citing IMMB is still suspended?

Item thirteen says different:

13
attach to its answering brief is granted. We have determined to resolve the petition without
The Division’s unopposed motion for leave to file exhibits that it inadvertently failed to
scheduling an in-person hearing. See Rule of Practice 550(b), 17 C.F.R. § 201.550(b) (stating (footnote continued . . . ) trading suspension is no longer in effect, we have the authority to resolve Immunotech’s petition on the merits.14 Among other things, our decision to address the substance of Immunotech’s arguments promotes the development of the record in the event Immunotech seeks judicial review.

The SEC filed the suspension citing the claim is misleading.

At that time the SEC had no clue about this company or it’s manufacturing of the ImmunH.

Which would make sense if you are a start up and you make a claim in regard of having a medicine that can fight Ebola head on, that would draw a lot of suspicion.

[NanoEE]

Your best option is to purchase at market, limit makes it very hard.

And just sit back and be patient.

[samsamsamiam]

Not uncommon to see a suspended stock just reshuffle assets elsewhere to continue pumping them.
The problem is if ENZC is doing the same thing this stock was suspended for?


https://www.sec.gov/litigation/opinions/2015/34-75790.pdf

[gringojoe]

Has anyone been able to buy shares?

[NanoEE]

Hours of Operation for the Lab.

Has anybody paid close attention to the Lab hours in the contact link?

https://www.immunotechlaboratoriesbg.com/contact-us

For what I could remember I thought Sat they were closed, can anybody confirm as a yay or nay to that question?

[Dodgeball]

Very weird action in expert market. MMs taking small trades where they can in the $0.01-0.015 range, then filling 100K share orders at 0.04. Where is the price? Hope they are just fishing to fill the higher prices. Lol.

[NanoEE]

Couldn’t agree more.

[Dodgeball]

$IMMB is not reporting. Harry has clammed up. Either a lot of $IMMB assets or some sleight of hand. But Harry does owe a fiduciary duty to $IMMB shareholders and don't think he'd jeopardize his massive gains on the ENZC side at the expense of $IMMB. Too risky when you are riding high. Guess we just have to be patient.

[NanoEE]

No, unfortunately I did not.

Didn’t know if you saw this new tab in their website:

https://enzolytics.com/our-science/

The IPF segment where they talk about Harry testing his patented ImmunH(ITV-1) with no mention of any company associated with that statement.

The lines are drawn for sure now.

IMMB sells ITV-1 through ITV-4 to ENZC now(I have a sneaky suspicion others are buying as well).

I am very curious to this coming quarterly report by both companies, looking for funds earned by means of sale or consulting fees.

[Dodgeball]

Curious, did you ever get a response from IMMB?

[Dodgeball]

Seems to be mixed assets between $IMMB and $ENZC. Just need a little more clarity to place a value on $IMMB.

[NanoEE]

Yes and yes. Looking forward to the next quarterly report, hopefully sooner than later.

The other detail I would like to hear more on is the building that they are outfitting to manufacture(GMP) the ITV-1.

[Dodgeball]

Agree. It has some value. In fact, it probably has considerable value, and probably most of the float locked up. It would be nice to know what we're worth. Harry needs to get this thing current so we can see the most recent financials and gauge market value from published quotes. Very hard to even know where you're at stuck on Expert Market. Fills have been all over the place, as high as $0.09, some of them decent sized. And considering the IP in play, may be worth much more.

[NanoEE]

This is a good hold.

Hear me out.

If for whatever reason Enzolytics is bought out, the patented compound Clone3 will go with ENZC, not the patented ImmunH(ITV-1). Which leaves Harry/The Zhabilov Group to carry the license agreement with IMMB, which I posted earlier that Harry has a 5% kick back on the sale of ITV-1.

So the patents that are under ENZC will need the ITV-1 material and the only way to get it is through IMMB.

If IMMB sells, which is a long shot. Harry doesn’t gain anything from this what’s so ever. Other than his 70 million shares in ENZC.

Hold onto IMMB!!!

[Dodgeball]

Another issue is Immunotech BG. IMMB owns 49%, then when Harry started ENZC, he claimed that ENZC owned Immunotech BG. Recently, ENZC stopped making that claim on its website, and now appears to be trying to void agreements with Immunotech BG. These once again appear to be assets belonging to IMMB shareholders that would be exposed if IMMB filings were made current, which Harry certainly seems to have the wherewithal to do. The question then is why keep IMMBs financials so quiet?

[NanoEE]

He has not transferred any rights of the patent to either ENZC or IMMB he has only signed over a licensing agreement with IMMB. I do not see a licensing agreement with ENZC.

So whatever IMMB produces and sells to ENZC Harry earns that 5% kick back.

[Dodgeball]

Was than an IMMB filing, or ENZC?

Still trying to sort out what the IMMB shareholders received for transactions with ENZC or Harry Z. And, of course, there is the core issue of whether IMMB ever, in fact, transferred the ITV-1 patent rights to ENCZ (and for what consideration.) Very difficult to untangle.

[NanoEE]

Sorry this is confusing.

See post below for clarity.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162087983

[NanoEE]

You are right.

My apologies.

Harry....The Zhabilov Trust, owns the patent to the ITV series.

When Harry gave rights to IMMB to manufacture his work(ITV-1) they gave him a hefty percent ownership(49%).

Harry flipped that ownership into ENZC, hence the 49% stake ENZC owns in IMMB.

Now the confusing part, both ENZC and IMMB claim patent holders to the ITV-1(ImmunH).

I speculate this is true because Harry is “involved” and tied to both.

What is going to come out of this could be good or bad for both companies, if the synergy is there this works. The Zhabilov’s are very wealthy.

The bad if either fails to deliver this is a ball of flames.

[NanoEE]

Money, money, money. Harry is going to be rolling in money big time.

Immunotech shall transfer a 49% interest in Immunotech to HARRY ZHABILOV.(which is now rolled into ENZC)

Upon Immunotech generating revenue from any kind of contractual agreement, i.e. milestone payments, patent licensing/sublicensing, royalties earned, Immunotech shall pay a five percent (5%) royalty on the amount of aggregate worldwide gross revenue, to be paid one-half to HARRY ZHABILOV.

Harry with 71,900,000 shares of ENZC
Diana with 6,000,000 shares of ENZC

There maybe more added to that since the March 2020 SEC filing I pulled that from.

[Dodgeball]

It sure looks like IMMB has the patent rights to ITV-1. Hope you get a response.

[NanoEE]

After re-reading and re-reading and re-reading the news release from yesterday on the website Accesswire and then re-reading it today.

The verbiage actually skirts the "ownership" of ITV-1(ImmunH).

Every reference to the "patent" of ITV-1 has/or is tagged with another part of the "compound or as an association as a compound".

In the bottom of the article when they talk about Enzolytics history, "compound ITV-1 (Immune Therapeutic Vaccine-1)" is a reference to his patent under ENZC as a "compound" not the actual ImmunH as a standalone patented material under ENZC.

I have emailed IMMB to see if they can clear up the ownership of the patent, but I don't think it's necessary for that confirmation.

It's pretty clear that the wording had to be digested a bit more than originally thought.

My claim, IMMB holds the patent to ImmunH(ITV-1).

[NanoEE]

We will see. Although Harry has said himself that he is not involved with BSSP, doesn’t mean he “can’t” be an employee.

I really don’t see how BSSP fits in the picture, but it’s a company built around software mostly and now they are going to start selling immune boosters?!?! Whatever, follow the money, right.

Once FDA approval hits any of one of the projects that Harry is working on we will know a lot more.

Gotta wonder where he is putting most of his time and into what.

Where does he see the greatest potential. ??

[Jerryk71]

Harry is still listed on $bssp that hasn't done anything. He was the scientist. Then he is linked to many other companies. Is he going to use it with them

[Dodgeball]

That's the issue. Who owns what? IF IMMB transferred IP to ENZC, what was the consideration? At one point there seemed to be such an arrangement contemplated for ENZC stock. If so, how much ENCZ stock does IMMB (and by extension IMMB investors) hold? But that is a big IF since the IP rights appear to be the subject of conflicting claims right now. Harry really needs to get the filings up to date so we can gauge what IMMB is worth and what rights it has.

[NanoEE]

Now! I am really confused about who owns what.

https://enzolytics.com/intellectual-property/.

If you read this website there is no reference to the patent of ITV-1.

If you read this article, it "sounds" like ENZC are the holders of the patent ITV-1. I called Accesswire to confirm who was making that statement in regards of the patent ITV-1, she informed me that ENZC emailed Accesswire to publish this article on the web.

https://www.accesswire.com/630985/Enzolytics-Updates-Permitting-Progress-in-Europe-on-Its-Planned-Clinical-Trials-of-Its-Patented-ITV-1-Anti-HIV-and-Other-Developments

Have to email Charles C or Harry to get down to the bottom of this.

Sounds like SEC filings are not up to date if this is the case.

Or ENZC is kicking the hornets nest with IMMB.

[Dodgeball]

Appreciate your insight. Certainly high risk/high reward. If I'm parsing the limited public domain information, IMMB also holds some amount of stock in ENZC. Looks like an ongoing dust up between Harry and Dimitar on rights to the IP and mfg in Bulgaria. Guessing at some point there will be a filing that exposes what IMMB is worth. Possibly even some form of settlement on the controversies. Agree it is a tough buy right now. Let's see where it goes.

[NanoEE]

Harry is only CEO to IMMB.

Charles C. Is CEO of ENZC

ENZC is licensed for the use of ITV-1. How long that licensed contract is, is the big question.

Hunch based, I don’t think ENZC is the only one using ITV-1 in the big Pharma world.

IMMB is probably selling this to others.

IMMB is a tough buy, good luck in your decision.

[Dodgeball]

Questions regarding filing status of IMMB and Harry Zhabilov:

According to Nevada Corporate search, current entity status is REVOKED as of annual report due date of 4/30/2018. This would mean no annual report was filed as of the 2018 due date and remains delinquent.

Harry Zhabilov is listed as President, Secy, Treasurer, and Director.

Is Harry still President/CEO of IMMB?

IMMB, it seems, owns 49% of Immunotech BG, and IMMB, it seems, owns important IP rights relative to ITV-1. On the new Enzolytics website, the references to ENZC owning 49% of Immunotech BG appear to have been removed.

So is Harry Z still CEO on BOTH companies? And also,

How much of the ENZC IP portfolio belongs to the shareholders of IMMB?

[Dodgeball]

$0.0101 to $0.043 range with most of the trades on the high side. Very weird action on this. Why would anyone put in a bid at $0.043 unless they were trying to scoop up shares?